IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Pharmacological autophagy enhancement constitutes a preclinically validated strategy for preventing or treating most major age-associated diseases. Driven by this consideration, we performed a high-content/high-throughput screen on 65 000 distinct compounds on a robotized fluorescence microscopy platform to identify novel autophagy inducers. RESULTS: Here, we report the discovery of picropodophyllin (PPP) as a potent inducer of autophagic flux that acts on-target, as an inhibitor of the tyrosine kinase activity of the insulin-like growth factor-1 receptor (IGF1R). Thus, PPP lost its autophagy-stimulatory activity in cells engineered to lack IGF1R or to express a constitutively active AKT serine/threonine kinase 1 (AKT1) mutant. When administered to cancer-bearing mice, PPP improved the therapeutic efficacy of chemoimmunotherapy with a combination of immunogenic cytotoxicants and programmed cell death 1 (PDCD1, better known as PD-1) blockade. These PPP effects were lost when tumors were rendered PPP-insensitive or autophagy-incompetent. In combination with chemotherapy, PPP enhanced the infiltration of tumors by cytotoxic T lymphocytes, while reducing regulatory T cells. In human triple-negative breast cancer patients, the activating phosphorylation of IGF1R correlated with inhibited autophagy, an unfavorable local immune profile, and poor prognosis. CONCLUSION: Altogether, these results suggest that IGF1R may constitute a novel and druggable therapeutic target for the treatment of cancer in conjunction with chemoimmunotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, pharmacological inhibition of IGF1R improves anticancer immunosurveillance, 217”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [217]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, enzymatic inhibition of IGF1R with tyrosine kinase inhibitors improves anticancer immunosurveillance requiring autophagy induction in malignant cells 142 .”
From Hallmarks of aging: An expanding universe (2023) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Self-citationExtending Healthy Life Span—From Yeast to Humans
Fontana, L., Partridge, L., & Longo, V. D. (2010) · Science · doi:10.1126/science.1172539 · Cited by 3,023
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationAutophagy modulation as a potential therapeutic target for diverse diseases
Rubinsztein, D. C., Codogno, P., & Levine, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3802 · Cited by 1,437 · cited 1×
“5 6 In the context of cancer, autophagy plays an ambiguous role.”
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377
Self-citationVarghese, F., Bukhari, A. B., Malhotra, R., & De, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096801 · Cited by 1,318
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Yamamoto, K., Venida, A., Yano, J., Biancur, D. E., Kakiuchi, M., Gupta, S., Sohn, A. S. W., Mukhopadhyay, S., Lin, E. Y., Parker, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2229-5 · Cited by 1,240
Autophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
Self-citationMetabolic control of autophagy
Galluzzi, L., Pietrocola, F., Levine, B., & Kroemer, G. (2014) · Cell · doi:10.1016/j.cell.2014.11.006 · Cited by 855
Self-citationRecent insights into the function of autophagy in cancer
Amaravadi, R., Kimmelman, A. C., & White, E. (2016) · Genes & Development · doi:10.1101/gad.287524.116 · Cited by 813
Autophagy as a promoter of longevity: insights from model organisms
Hansen, M., Rubinsztein, D. C., & Walker, D. W. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0033-y · Cited by 754
Metabolic Control of Longevity
López-Otín, C., Galluzzi, L., Freije, J. M. P., Madeo, F., & Kroemer, G. (2016) · Cell · doi:10.1016/j.cell.2016.07.031 · Cited by 753
Self-citationRegulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway
Tallóczy, Z., Jiang, W., Virgin, H. W., Leib, D. A., Scheuner, D., Kaufman, R. J., Eskelinen, E.-L., & Levine, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012485299 · Cited by 741
p53 status determines the role of autophagy in pancreatic tumour development
Rosenfeldt, M. T., O’Prey, J., Morton, J. P., Nixon, C., MacKay, G., Mrowinska, A., Au, A., Rai, T. S., Zheng, L., Ridgway, R., et al. (2013) · Nature · doi:10.1038/nature12865 · Cited by 713
Ma, Y., Adjemian, S., Mattarollo, S. R., Yamazaki, T., Aymeric, L., Yang, H., Portela Catani, J. P., Hannani, D., Duret, H., Steegh, K., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.003 · Cited by 699
Self-citationT cell stemness and dysfunction in tumors are triggered by a common mechanism
Vodnala, S. K., Eil, R., Kishton, R. J., Sukumar, M., Yamamoto, T. N., Ha, N.-H., Lee, P.-H., Shin, M., Patel, S. J., Yu, Z., et al. (2019) · Science · doi:10.1126/science.aau0135 · Cited by 552
Caloric restriction mimetics enhance anticancer immunosurveillance
Pietrocola, F., Pol, J., Vacchelli, E., Rao, S., Enot, D. P., Baracco, E. E., Levesque, S., Castoldi, F., Jacquelot, N., Yamazaki, T., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.016 · Cited by 542 · cited 3×
“…auto-phagy is required for maintaining cellular homeostasis and genomic stability, 9 as well as for facilitating anticancer immunosurveil-lance, 5 meaning that the inhibition of auto-phagy spurs carcinogenesis 10 11 and disabled autophagy actually constitutes a poor prognostic marker in some…”
Self-citationLópez-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499
Self-citationAutophagy and the cell biology of age-related disease
Leidal, A. M., Levine, B., & Debnath, J. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0235-8 · Cited by 424
Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth
Girnita, A., Girnita, L., Prete, F. D., Bartolazzi, A., Larsson, O., & Axelson, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2522 · Cited by 363
Fassnacht, M., Berruti, A., Baudin, E., Demeure, M. J., Gilbert, J., Haak, H., Kroiss, M., Quinn, D. I., Hesseltine, E., Ronchi, C. L., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70081-1 · Cited by 339
Karasic, T. B., O’Hara, M. H., Loaiza-Bonilla, A., Reiss, K. A., Teitelbaum, U. R., Borazanci, E., De Jesus-Acosta, A., Redlinger, C., Burrell, J. A., Laheru, D. A., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0684 · Cited by 293
Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity
Shen, S., Niso-Santano, M., Adjemian, S., Takehara, T., Malik, S. A., Minoux, H., Souquere, S., Mariño, G., Lachkar, S., Senovilla, L., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.013 · Cited by 285
Self-citationeIF2α phosphorylation is pathognomonic for immunogenic cell death
Bezu, L., Sauvat, A., Humeau, J., Gomes-da-Silva, L. C., Iribarren, K., Forveille, S., Garcia, P., Zhao, L., Liu, P., Zitvogel, L., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0044-9 · Cited by 241
Self-citationThe Role of Autophagy in Cancer
Santana-Codina, N., Mancias, J. D., & Kimmelman, A. C. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-041816-122338 · Cited by 201
Repair, Reuse, Recycle: The Expanding Role of Autophagy in Genome Maintenance
Hewitt, G., & Korolchuk, V. I. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.011 · Cited by 172
Vasilcanu, D., Girnita, A., Girnita, L., Vasilcanu, R., Axelson, M., & Larsson, O. (2004) · Oncogene · doi:10.1038/sj.onc.1208065 · Cited by 166
Vitale, G., Pellegrino, G., Vollery, M., & Hofland, L. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00027 · Cited by 166
Visualizing Cellular Phosphoinositide Pools with GFP-Fused Protein-Modules
Balla, T., & Várnai, P. (2002) · Science's STKE · doi:10.1126/stke.2002.125.pl3 · Cited by 147
Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy
Troncoso, R., Vicencio, J. M., Parra, V., Nemchenko, A., Kawashima, Y., del Campo, A., Toro, B., Battiprolu, P. K., Aranguiz, P., Chiong, M., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr321 · Cited by 138
Wang, Y., Xiong, H., Liu, D., Hill, C., Ertay, A., Li, J., Zou, Y., Miller, P., White, E., Downward, J., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1569912 · Cited by 134
TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves
Enot, D. P., Vacchelli, E., Jacquelot, N., Zitvogel, L., & Kroemer, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1462431 · Cited by 124
Self-citationGirnita, A., All‐Ericsson, C., Economou, M. A., Astr√∂m, K., Axelson, M., Seregard, S., Larsson, O., & Girnita, L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1106 · Cited by 120 · cited 1×
“IGF1R activation as a negative prognostic factor in breast cancer A paucity in LC3B puncta, reflecting disabled autophagy in malignant cells, is associated with dismal prognosis of breast cancer, as well as an unfavorable ratio of tumor infiltrating CD8 + cytotoxic T lymphocytes (CTLs) over FOXP3 +…”
Ladoire, S., Enot, D., Senovilla, L., Ghiringhelli, F., Poirier-Colame, V., Chaba, K., Semeraro, M., Chaix, M., Penault-Llorca, F., Arnould, L., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1154244 · Cited by 117
Self-citationLadoire, S., Penault-Llorca, F., Senovilla, L., Dalban, C., Enot, D., Locher, C., Prada, N., Poirier-Colame, V., Chaba, K., Arnould, L., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1082022 · Cited by 113 · cited 1×
“12 On the other hand, autophagy enhances the fitness of cancer cells and allows them to avoid cell death induction in response to cytotoxicants or targeted therapies.”
Self-citationAspirin Recapitulates Features of Caloric Restriction
Pietrocola, F., Castoldi, F., Markaki, M., Lachkar, S., Chen, G., Enot, D. P., Durand, S., Bossut, N., Tong, M., Malik, S. A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.024 · Cited by 111
Self-citationTemporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk
Cassidy, L. D., Young, A. R. J., Young, C. N. J., Soilleux, E. J., Fielder, E., Weigand, B. M., Lagnado, A., Brais, R., Ktistakis, N. T., Wiggins, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14187-x · Cited by 108 · cited 1×
“…is required for maintaining cellular homeostasis and genomic stability, 9 as well as for facilitating anticancer immunosurveil-lance, 5 meaning that the inhibition of auto-phagy spurs carcinogenesis 10 11 and disabled autophagy actually constitutes a poor prognostic marker in some cancers.”
Jones, R. L., Kim, E. S., Nava-Parada, P., Alam, S. M., Johnson, F. M., Stephens, A. W., Simantov, R., Poondru, S., Gedrich, R., Lippman, S. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0265 · Cited by 104
Berndt, N., Yang, H., Trinczek, B., Betzi, S., Zhang, Z., Wu, B., Lawrence, N. J., Pellecchia, M., Schönbrunn, E., Cheng, J. Q., et al. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2010.63 · Cited by 93
Lévesque, S., Le Naour, J., Pietrocola, F., Paillet, J., Kremer, M., Castoldi, F., Baracco, E. E., Wang, Y., Vacchelli, E., Stoll, G., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1657375 · Cited by 86
Self-citationEffect of IGF‐1 on the balance between autophagy of dysfunctional mitochondria and apoptosis
Gu, Y., Wang, C., & Cohen, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.040 · Cited by 84 · cited 1×
“13 Thus, the effects of autophagy modulation on tumor progression are highly context dependent.”
Phosphorylation of eukaryotic initiation factor-2α (eIF2α) in autophagy
Humeau, J., Leduc, M., Cerrato, G., Loos, F., Kepp, O., & Kroemer, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2642-6 · Cited by 84
Self-citationMacaulay, V. M., Middleton, M. R., Eckhardt, S., Rudin, C. M., Juergens, R. A., Gedrich, R. W., Gogov, S., McCarthy, S. P., Poondru, S., Stephens, A. W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2218 · Cited by 70
von Mehren, M., George, S., Heinrich, M. C., Schuetze, S. M., Yap, J. T., Yu, J., Abbott, A., Litwin, S., Crowley, J. J., Belinsky, M. G., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1069 · Cited by 70
Chen, G., Xie, W., Nah, J., Sauvat, A., Liu, P., Pietrocola, F., Sica, V., Carmona‐Gutierrez, D., Zimmermann, A., Pendl, T., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910469 · Cited by 64
Self-citationAutophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
Wang, Y., Xie, W., Humeau, J., Chen, G., Liu, P., Pol, J., Zhang, Z., Kepp, O., & Kroemer, G. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000462 · Cited by 63
Self-citationStarvation, detoxification, and multidrug resistance in cancer therapy
Lee, C., Raffaghello, L., & Longo, V. D. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.004 · Cited by 62
Matsubara, J., Yamada, Y., Nakajima, T. E., Kato, K., Hamaguchi, T., Shirao, K., Shimada, Y., & Shimoda, T. (2008) · Oncology · doi:10.1159/000139127 · Cited by 54
Bendell, J. C., Jones, S. F., Hart, L. L., Spigel, D. R., Lane, C. M., Earwood, C., Infante, J. R., Barton, J. H., & Burris, H. A. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0177-3 · Cited by 47
de Groot, S., Charehbili, A., van Laarhoven, H. W. M., Mooyaart, A. L., Dekker-Ensink, N. G., van de Ven, S., Janssen, L. G. M., Swen, J. J., Smit, V. T. H. B. M., Heijns, J. B., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-015-0663-3 · Cited by 47
Wengrod, J. C., & Gardner, L. B. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1056947 · Cited by 45
Emdal, K. B., Pedersen, A.-K., Bekker-Jensen, D. B., Lundby, A., Claeys, S., De Preter, K., Speleman, F., Francavilla, C., & Olsen, J. V. (2018) · Science Signaling · doi:10.1126/scisignal.aap9752 · Cited by 42
Growth factors stimulate anabolic metabolism by directing nutrient uptake
Thompson, C. B., & Bielska, A. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aw119.008146 · Cited by 41
Oza, A. M., Kaye, S. B., Tornout, J. V., Sessa, C., Gore, M. E., Naumann, R. W., Hirte, H. W., Colombo, N., Chen, J., Gorla, S. R., et al. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.01.019 · Cited by 38
Bergqvist, M., Holgersson, G., Bondarenko, I., Grechanaya, E., Maximovich, A., Andor, G., Klockare, M., Thureson, M., Jerling, M., & Harmenberg, J. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1253866 · Cited by 35 · cited 1×
“IGF1R activation as a negative prognostic factor in breast cancer A paucity in LC3B puncta, reflecting disabled autophagy in malignant cells, is associated with dismal prognosis of breast cancer, as well as an unfavorable ratio of tumor infiltrating CD8 + cytotoxic T lymphocytes (CTLs) over FOXP3 +…”
Quantification of cellular viability by automated microscopy and flow cytometry
Sauvat, A., Wang, Y., Segura, F., Spaggiari, S., Müller, K., Zhou, H., Galluzzi, L., Kepp, O., & Kroemer, G. (2015) · Oncotarget · doi:10.18632/oncotarget.3266 · Cited by 33
Self-citationIsobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy
Wu, Q., Tian, A.-L., Durand, S., Aprahamian, F., Nirmalathasan, N., Xie, W., Liu, P., Zhao, L., Zhang, S., Pan, H., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03226-x · Cited by 31
Self-citationKepp, O., Chen, G., Carmona‐Gutiérrez, D., Madeo, F., & Kroemer, G. (2019) · Autophagy · doi:10.1080/15548627.2019.1688984 · Cited by 29
Self-citationAutophagy-mediated metabolic effects of aspirin
Castoldi, F., Humeau, J., Martins, I., Lachkar, S., Loew, D., Dingli, F., Durand, S., Enot, D., Bossut, N., Chery, A., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00365-0 · Cited by 27
Self-citationPicropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo
Tarnowski, M., Tkacz, M., Zgutka, K., Bujak, J., Kopytko, P., & Pawlik, A. (2017) · BMC Cancer · doi:10.1186/s12885-017-3495-y · Cited by 22 · cited 1×
“IGF1R activation as a negative prognostic factor in breast cancer A paucity in LC3B puncta, reflecting disabled autophagy in malignant cells, is associated with dismal prognosis of breast cancer, as well as an unfavorable ratio of tumor infiltrating CD8 + cytotoxic T lymphocytes (CTLs) over FOXP3 +…”
Alternative Cytotoxic Effects of the Postulated IGF-IR Inhibitor Picropodophyllin In Vitro
Wu, X., Sooman, L., Wickström, M., Fryknäs, M., Dyrager, C., Lennartsson, J., & Gullbo, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0091 · Cited by 17
Puncta intended: connecting the dots between autophagy and cell stress networks
Ho, C. J., Samarasekera, G., Rothe, K., Xu, J., Yang, K., Leung, E. W., Chan, M., Jiang, X., & Gorski, S. M. (2020) · Autophagy · doi:10.1080/15548627.2020.1775394 · Cited by 14
Schirripa, M., Zhang, W., Heinemann, V., Cao, S., Okazaki, S., Yang, D., Loupakis, F., Berger, M. D., Ning, Y., Miyamoto, Y., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30715 · Cited by 11
Davis, S. L., Eckhardt, S., Diamond, J. R., Messersmith, W. A., Dasari, A. N., Weekes, C. D., Lieu, C. H., Kane, M., Tan, A. C., Pitts, T. M., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0315 · Cited by 10
Cited by
Hallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549
Self-citationThe hallmarks of cancer immune evasion
Galassi, C., Chan, T. A., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 565
Targeting immunogenic cell stress and death for cancer therapy
Galluzzi, L., Guilbaud, E., Schmidt, D., Kroemer, G., & Marincola, F. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00920-9 · Cited by 538
“In line with this notion, autophagy inhibition downstream of insulin-like growth factor 1 receptor (IGF1R) hyperactivation is a poor prognostic marker coupled with signs of deficient immunosurveillance in breast cancer 130 .”
Self-citationMeta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Self-citationDietary regulation in health and disease
Wu, Q., Gao, Z.-J., Yu, X., & Wang, P. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01104-w · Cited by 176
Self-citation
Metadata
- Authors
- Wu, Q., Tian, A.-L., Li, B., Leduc, M., Forveille, S., Hamley, P., Galloway, W., Xie, W., Liu, P., Zhao, L., Zhang, S., Hui, P., Madeo, F., Tu, Y., Kepp, O., & Kroemer, G.
- Affiliations
- Inserm (FR)
- Renmin Hospital of Wuhan University (CN)
- Samsara Therapeutics Ltd, Oxford, UK
- Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France
- University of Graz (AT)
- Karolinska University Hospital (SE)
- Corresponding author
- Tu, Yi
- Kepp, Oliver
- Kroemer, Guido
- ORCID
- Venue
- Journal for ImmunoTherapy of Cancer
- Publisher
- BMJ
- Published
- 2021-06
- Volume
- 9
- Issue
- 6
- Pages
- e002722
- ISSN
- 2051-1426 (ISSN-L)
- PMC
- PMC8204183
- OpenAlex
- W3166418545
- Cited by
- 83
- References
- 64
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 17 · 2023: 16 · 2022: 20 · 2021: 5
- FWCI
- 10.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal for ImmunoTherapy of Cancer (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Association pour la recherche sur le cancer
- BioTechMed
- University of Graz (Fast4Health)
- Université Paris-Saclay, Plateforme Imagerie
- Île de France (DIM Elicit)
- Ligue Contre le Cancer
- Natural Science Foundation of Hubei Province (2020CFA026)
- Agence National de la Recherche (Projets blancs)
- European Union
- Fondation pour la Recherche Médicale
- High-end Foreign Expert Program in China (GDW20171100085)
- Fondation Carrefour
- IdEx Université de Paris ANR (18-IDEX-0001)
- Labex (ANR-18-IDEX-0001)
- Austrian Federal Ministry of Education, Science and Research (BMWFW-80.109/0001-WF/V/3b/2015))
- Austrian Science Fund (W1226, P27893, P29203,P29262,P31727, SFB LIPOTOX F3007 & F3012)
- Chinese Scholarship Council
- AMMICa (US23/CNRS UMS3655)
- Association Ruban Rose
- Canceropôle Île de France
- Elior
- Equipex Onco-Pheno-Screen
- European Joint Program on Rare Disease
- Gustave Roussy (Odyssea)
- European Union Horizon 2020 Projects (Oncobiome and Crimson)
- Institut National Du Cancer
- INSERM
- Institut Universitaire de France
- RHU Torino Lumière
- Seerave Foundation
- SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination
- SIRIC Cancer Research and Personalized Medicine
- NAWI Granz (BioHealth)
- BioTechMed-Graz (EPIAge)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- IGF-1 receptor, picropodophyllin, autophagy, AKT1, chemoimmunotherapy, anti-PD-1 therapy, regulatory T cells, triple-negative breast cancer, combination cancer therapy, autophagy enhancers
- MeSH terms
- Animals, Antineoplastic Agents, Autophagy, Female, Humans, Receptor, IGF Type 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.